Mohammad Bashashati, MD
Affiliations: | Physiology and Pharmacology | University of Calgary, Calgary, Alberta, Canada |
Google:
"Mohammad Bashashati"Mean distance: 16.48 (cluster 40) | S | N | B | C | P |
Cross-listing: Neurotree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Robles A, Perez Ingles D, Myneedu K, et al. (2019) Mast cells are increased in the small intestinal mucosa of patients with irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. e13718 |
| Ingles PP, Peoker A, Robles A, et al. (2018) Mucosal Mast Cells Are Increased in the Small Intestine of Patients With Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis American Journal of Gastroenterology. 113: S261-S262 |
| Bashashati M, Moossavi S, Cremon C, et al. (2017) Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society |
| Bashashati M, Fichna J, Piscitelli F, et al. (2017) Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT). Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 29 |
| Zielińska M, Fichna J, Bashashati M, et al. (2017) G protein-coupled estrogen receptor and estrogen receptor ligands regulate colonic motility and visceral pain. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 29 |
| Bashashati M, Nasser Y, Keenan CM, et al. (2015) Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation. British Journal of Pharmacology. 172: 3099-111 |
| Bashashati M, Habibi HR, Keshavarzian A, et al. (2015) Intestinal microbiota: a regulator of intestinal inflammation and cardiac ischemia? Current Drug Targets. 16: 199-208 |
| Keenan CM, Storr MA, Thakur GA, et al. (2015) AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner. British Journal of Pharmacology. 172: 2406-18 |
| Bashashati M, Rezaei N, Quigley EM, et al. (2015) Mo2042 TNFα in Irritable Bowel Syndrome (IBS): From Gene Polymorphisms to Circulating Levels Gastroenterology. 148: S-777 |
| Bashashati M, Keenan CM, Burkhardt W, et al. (2015) 386 Endocannabinoid-Mediated Effects of Substrate-Selective COX-2 Inhibitors on Gastrointestinal Motility in the Mouse Gastroenterology. 148: S-80 |